Brought to you by:
Houston, we have a dialysis access problem
The concept of dedicated vascular access centers fuels a turbocharged Texan tussle with Karl Illig, MD, of Flow Vascular Institute in Houston, taking on Eric Peden, MD, an associate professor of cardiovascular surgery at Houston Methodist Hospital, in a no-holds-barred debate…
VAM 2022 will offer innovative formats
The Society for Vascular Surgery (SVS) Postgraduate Education Committee is breaking up the format in favor of change and innovation for two sessions at this year’s Vascular Annual Meeting (VAM). These in-person-only events will involve both networking and social media. …
AVF 2022: Emerging autogenous venous valve formation system sees ‘continual improvement’
An emerging endovenous valve formation system designed to treat patients with chronic venous insufficiency (CVI) with evidence of deep venous reflux has demonstrated continual improvement since U.S. investigators started performing clinical cases with the device 18 months ago, according to…
FDA advisory panel issues recommendations on lifelong surveillance for EVAR
The Food and Drug Administration (FDA) recently announced it has issued a letter to healthcare providers emphasizing the importance of lifelong surveillance, including imaging, for patients with abdominal aortic aneurysm (AAA) endovascular aneurysm repair (EVAR). “Regular imaging surveillance, within 30-days…
Time’s nearly up: Apply for VAM travel scholarships by March 9
Time is quickly running out for medical students and general surgery residents to apply for Society for Vascular Surgery (SVS) travel scholarships to attend the 2022 Vascular Annual Meeting (VAM) in Boston this June. “I wasn’t sure what I wanted…
Tickets selling briskly for Gala: ‘Cheers to 75 Years’
More than 330 people have registered their intentions to raise a glass to toast the Society for Vascular Surgery’s quarter-century of helping vascular patients during the Vascular Annual Meeting (VAM) in Boston this summer. They have already purchased tables…
AVF 2022: Six-month CLOUT data indicate ClotTriever can effectively remove full spectrum of thrombus
Six-month outcomes from the ongoing CLOUT registry demonstrate the “safety and efficacy” of the ClotTriever thrombectomy system in a real-world deep vein thrombosis (DVT) population regardless of clot chronicity level, the 2022 annual meeting of the American Venous Forum (AVF)…
AVF 2022: VenoValve improvement ‘maintained’ for 2.5 years without adverse events
Envveno Medical announced positive 30-month data from the first-in-human trial of the VenoValve bioprosthetic potential venous valve replacement during the 2022 American Venous Forum (AVF) annual meeting (VENOUS2022) held in Orlando, Florida (Feb. 23–26). The results showed that VenoValve recipients—now an…
VAM 2022: More science, discussion, streaming
With abstract selection finished this month and the lineup of many other sessions in place, organizers are excited about the offerings of the 2022 Vascular Annual Meeting (VAM). VAM 2022 will be held June 15–18 at the Hynes Convention Center…
Sex discordance and postoperative outcomes: We should be vigilant of a real disparity in health outcomes
The recent JAMA Surgery publication “Association of surgeon-patient sex concordance with postoperative outcomes” is a population-based, retrospective cohort study of more than 1 million patients that concluded “sex discordance between surgeons and patients negatively affected outcomes following common procedures.”1 Furthermore,…